Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adverse Drug Reactions
Etanercept therapy for rheumatoid arthritis evaluated over 4 years
August 11th, 2005
The effect of etanercept therapy for rheumatoid arthritis was evaluated over 4 years. "The tumor necrosis factor blocking agent etanercept is effective in the treatment of chronic inflammatory diseases. Previously published studies provided no evidence for an elevated frequency of severe adverse events under therapy," scientists in Germany reported. "The present work documents efficacy and safety of long-term treatment with etanercept up to 4 years in 29 patients with rheumatoid arthritis in single German study center. Follow-up examinations were conducted at monthly intervals. The response was assessed in an intention-to-treat analysis (last...
Source: Women's Health Weekly (2005-08-11)
|
